Turning strength into weakness: protein degradation and autophagy as therapeutic targets in glioblastoma?
Neuro Oncol
.
2021 Jul 1;23(7):1041-1043.
doi: 10.1093/neuonc/noab099.
Authors
Simone P Niclou
1
2
,
Anna Golebiewska
1
Affiliations
1
NORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg.
2
Department of Biomedicine, University of Bergen, Bergen, Norway.
PMID:
33864093
PMCID:
PMC8263154
DOI:
10.1093/neuonc/noab099
No abstract available
Publication types
Editorial
Comment
MeSH terms
Autophagy
Brain Neoplasms* / drug therapy
Glioblastoma* / drug therapy
Humans
Proteolysis